These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35761108)

  • 1. Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis.
    Wu C; Ying J; Dai M; Peng J; Zhang D
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3385-3398. PubMed ID: 35761108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.
    Li D; Yang Z; Liu Z; Zou Q; Yuan Y
    Pathol Oncol Res; 2019 Jan; 25(1):157-167. PubMed ID: 29043607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Long Non-Coding RNA (lncRNA) Colon Cancer-Associated Transcript-1 (CCAT1) Suppresses Oral Squamous Cell Carcinoma Proliferation, Invasion, and Migration by Inhibiting the Discoidin Domain Receptor 2 (DDR2)/ERK/AKT Axis.
    Sun M; Shen Z
    Med Sci Monit; 2020 Feb; 26():e920020. PubMed ID: 32009633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.
    Gonzalez ME; Martin EE; Anwar T; Arellano-Garcia C; Medhora N; Lama A; Chen YC; Tanager KS; Yoon E; Kidwell KM; Ge C; Franceschi RT; Kleer CG
    Cell Rep; 2017 Jan; 18(5):1215-1228. PubMed ID: 28147276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
    Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
    Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma.
    Park JW; Lee YS; Kim JS; Lee SK; Kim BH; Lee JA; Lee NO; Kim SH; Hong EK
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1973-83. PubMed ID: 25842034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
    Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
    J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.
    Xu J; Lu W; Zhang S; Zhu C; Ren T; Zhu T; Zhao H; Liu Y; Su J
    Cancer Biol Ther; 2014 May; 15(5):612-22. PubMed ID: 24556606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA-100219 promotes breast cancer progression by binding to microRNA-485-3p.
    Yao Y; Fang ZZXHSLCNH
    J BUON; 2019; 24(2):501-508. PubMed ID: 31127997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.
    Corsa CA; Brenot A; Grither WR; Van Hove S; Loza AJ; Zhang K; Ponik SM; Liu Y; DeNardo DG; Eliceiri KW; Keely PJ; Longmore GD
    Cell Rep; 2016 Jun; 15(11):2510-23. PubMed ID: 27264173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
    Grither WR; Divine LM; Meller EH; Wilke DJ; Desai RA; Loza AJ; Zhao P; Lohrey A; Longmore GD; Fuh KC
    Oncogene; 2018 Mar; 37(13):1714-1729. PubMed ID: 29348456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients.
    Miao L; Wang Y; Zhu S; Shi M; Li Y; Ding J; Yang J; Ye Q; Cai H; Zhang D; Liu H; Song Y
    BMC Cancer; 2014 May; 14():369. PubMed ID: 24885564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer.
    Yang J; Li L; Xi Y; Sun R; Wang H; Ren Y; Zhao L; Wang X; Li X
    Cancer Sci; 2018 Oct; 109(10):3115-3128. PubMed ID: 29770536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3.
    Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y
    Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR-194-5p.
    Mao Q; Lv M; Li L; Sun Y; Liu S; Shen Y; Liu Z; Luo S
    J Cell Physiol; 2020 Mar; 235(3):2668-2675. PubMed ID: 31490021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
    Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.
    Lui AJ; Geanes ES; Ogony J; Behbod F; Marquess J; Valdez K; Jewell W; Tawfik O; Lewis-Wambi J
    Cancer Lett; 2017 Jul; 399():29-43. PubMed ID: 28411130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells.
    Zhao YS; Yang WC; Xin HW; Han JX; Ma SG
    Yonsei Med J; 2019 Feb; 60(2):148-157. PubMed ID: 30666836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 47 (HSP47) binds to discoidin domain-containing receptor 2 (DDR2) and regulates its protein stability.
    Chen J; Wang S; Zhang Z; Richards CI; Xu R
    J Biol Chem; 2019 Nov; 294(45):16846-16854. PubMed ID: 31570520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer.
    Romayor I; García-Vaquero ML; Márquez J; Arteta B; Barceló R; Benedicto A
    Breast J; 2022; 2022():5169405. PubMed ID: 35711892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.